Direct compression formulation of DPPIV inhibitors and glitazones, and process

Details for Australian Patent Application No. 2006258013 (hide)

Owner Novartis AG

Inventors Lakshman, Jay Parthiban; Kowalski, James; Patel, Arun P.

Agent Davies Collison Cave

Pub. Number AU-A-2006258013

PCT Pub. Number WO2006/135693

Priority 60/689,739 10.06.05 US; 60/690,527 14.06.05 US; 60/690,814 15.06.05 US

Filing date 8 June 2006

Wipo publication date 21 December 2006

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4439 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/135693 Priority application(s): WO2006/135693

16 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006258027-High starch light weight gypsum wallboard

2006258012-Processes for the preparation of docetaxel